Article
Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study.
European urology oncology - 1 Dec 2024
Amini Andrew E, Hunter Alexandra E, Almashad Aya, Feng Aileen J, Patel Neel D, O'Dea Margaret R, McCormick Shelley R, Rodgers Linda H, Salari Keyan
Abstract excerpt
BACKGROUND: The risk of early-onset and clinically aggressive prostate cancer is elevated in carriers of certain rare pathogenic germline mutations. The utility of augmenting traditional prostate-specific antigen (PSA)-based screening measures with multiparametric magnetic resonance imaging (MRI) in this population is not yet known. OBJECTIVE: To evaluate MRI-based screening in comparison with traditional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.